The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer

  • Authors:
    • Yunyan Wu
    • Fuyuki Sato
    • Toshiyuki Yamada
    • Ujjal Kumar Bhawal
    • Takeshi Kawamoto
    • Katsumi Fujimoto
    • Mitsuhide Noshiro
    • Hiroko Seino
    • Satoko Morohashi
    • Kenichi Hakamada
    • Yoshimitsu Abiko
    • Yukio Kato
    • Hiroshi Kijima
  • View Affiliations

  • Published online on: July 18, 2012     https://doi.org/10.3892/ijo.2012.1559
  • Pages: 1337-1346
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

DEC1 (BHLHE40/Stra13/Sharp2) is a basic helix-loop-helix (bHLH) transcription factor that is involved in the regulation of apoptosis and cell proliferation and the response to hypoxia. Epithelial-mesenchymal transition (EMT) is an important step leading to invasion and migration of various tumor cells, and TGF-β treatment has been shown to induce cancer cells to undergo EMT. However, the significance of DEC1 in TGF-β-induced EMT remains unknown. We examined the role of DEC1 in EMT of PANC-1 cells, a human pancreatic cancer cell line. As a result, we found that DEC1 was upregulated by TGF-β in PANC-1 cells, and regulated the expression and the levels of nuclear, cytoplasmic or membrane localization of EMT-related factors, including phosphorylated Smad3 (pSmad3), snail, claudin-4 and N-cadherin. In the presence of TGF-β, DEC1 knockdown by siRNA inhibited morphological changes during EMT processes, while TGF-β induced PANC-1 cells to taken on a spindle-shaped morphology. Furthermore, a combination treatment of DEC1 expression with TGF-β was closely linked to the migration and invasion of PANC-1 cells. Immunohistochemically, DEC1 and pSmad3 were detected within pancreatic cancer tissues, whereas claudin-4 expression was weaker in the cancer tissues compared with the adjacent non-cancer pancreatic tissues. These findings suggest that DEC1 plays an important role in the regulation of these EMT-related factors in pancreatic cancer.
View Figures
View References

Related Articles

Journal Cover

October 2012
Volume 41 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu Y, Sato F, Yamada T, Bhawal UK, Kawamoto T, Fujimoto K, Noshiro M, Seino H, Morohashi S, Hakamada K, Hakamada K, et al: The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer. Int J Oncol 41: 1337-1346, 2012.
APA
Wu, Y., Sato, F., Yamada, T., Bhawal, U.K., Kawamoto, T., Fujimoto, K. ... Kijima, H. (2012). The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer. International Journal of Oncology, 41, 1337-1346. https://doi.org/10.3892/ijo.2012.1559
MLA
Wu, Y., Sato, F., Yamada, T., Bhawal, U. K., Kawamoto, T., Fujimoto, K., Noshiro, M., Seino, H., Morohashi, S., Hakamada, K., Abiko, Y., Kato, Y., Kijima, H."The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer". International Journal of Oncology 41.4 (2012): 1337-1346.
Chicago
Wu, Y., Sato, F., Yamada, T., Bhawal, U. K., Kawamoto, T., Fujimoto, K., Noshiro, M., Seino, H., Morohashi, S., Hakamada, K., Abiko, Y., Kato, Y., Kijima, H."The BHLH transcription factor DEC1 plays an important role in the epithelial-mesenchymal transition of pancreatic cancer". International Journal of Oncology 41, no. 4 (2012): 1337-1346. https://doi.org/10.3892/ijo.2012.1559